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Abstract
Coagulase-negative staphylococci and Staphylococcus aureus are the commonest pathogens involved
in infections of pacemaker-defibrillator systems. Among causative Gram-negative bacteria, infections
due to Klebsiella, Serratia, Pseudomonas, Acinetobacter and other species have been reported. We
report herein a unique case of an automatic implantable cardioverter defibrillator infection due to
Providencia rettgeri in a 65-year-old male who was admitted to our service with bacteremia and
infection of the generator and subcutaneous array in a recently implanted device.
Introduction
Insertion of an automatic implantable cardioverter-defibril-
lator (ICD) reduces the occurrence of sudden death in
patients at risk for ventricular tachycardia or ventricular
fibrillation [1]. Despite the advent of transvenously placed
devices and improvements in surgical techniques, device
infection is still a serious complication due to associated
morbidity,mortality and financial costs [2]. Management of
this clinical entity is challenging since no current guidelines
are available for optimal treatment. We present a case of an
ICD pocket infection due to an uncommon pathogen.
Case presentation
This is a case of a 65-year-old Jewish male who presented
to our hospital complaining of a two-week history of sero-
sanguineous oozing coming from a healing surgical
wound overlying an ICD that had been implanted sixteen
days prior to the day of admission at a different medical
center. No purulent discharge was seen. The area became
increasingly painful. The patient denied any fevers, chills,
palpitations or other cardiovascular symptoms on admis-
sion. Vital signs were as follows: Temperature of 98.4°F,
Blood pressure of 105/64 mmHg, Heart rate of 60 beats
per minute, Respiratory rate of 14 breaths per minute
and Oxygen saturation of 98% on room air. Physical
examination revealed an eight-centimeter irregularly oval,
warm, swollen, erythematous and tender area on the left
anterior-superior chest wall. No local ulcers or new heart
murmurs were noticed. Poor dentition, together with the
presence of disheveling appearance was appreciated.
Past medical history was positive for non-ischemic dilated
cardiomyopathy, congestive heart failure (NYHA class III),
atrial fibrillation, essential hypertension and a recent
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syncopal episode. The patient had no history of alcohol,
tobacco or illegal drug abuse. He was a retired messenger
since 2004 and lived in a shelter. No family history of
cardiomyopathy or oncologic diseases was noted.
Admission laboratory findings revealed mild leukocytosis
together with mild normocytic normochromic anemia
(Table 1). An electrocardiogram showed atrial paced
rhythm at 60 beats per minute, a QRS complex of 102
msec and a QTc interval of 480 sec, no signs of ischemia
were recorded. His home medications included Warfarin,
Carvedilol, Lisinopril and Simvastatin.
Providencia rettgeri grew in two sets of deep wound
cultures, one set of superficial wound cultures, one set of
peripheral blood cultures obtained on the day of admis-
sion as well as from the culture of the removed device. The
antibiotic resistance pattern was similar in all the cultures
(Table 2). A trans-esophageal echocardiography did not
reveal vegetations or signs of endocarditis.
The entire implanted system, including the cardiac leads of
a dual chamber cardioverter-defibrillator, Medtronic®,
model D224DRG, Secura DR was removed on day two
of admission. The wound was left opened, and dry to wet
dressings were applied locally. Resolution of the infection
was seen after the patient received a four-week course of
intravenous Cefepime two grams every twelve hours,
subsequent surveillance blood cultures revealed no growth
and second intention healing of the surgical wound
ensued. An external defibrillator vest was initially placed
and as soon as the antibiotic regimen was completed a
new dual chamber cardioverter-defibrillator was placed on
the right side of the thoracic wall. The patient was
subsequently discharged with adequate follow-up.
Discussion
Providencia rettgeri (PR) has been frequently associated with
colonization of indwelling urinary catheters and urinary
tract infections, bacteremias, skin infections, traveler’s
diarrhea, etc [3,4]. To the best of our knowledge, this
microorganism has never been implicated in infections of
automatic ICD, being this case the first one ever reported in
the literature as evidenced by a MEDLINE database search.
Axillae, human feces, urine, throat andperineumcould serve
as potential reservoirs for Providencia species, mainly in
chronic debilitated patients. Exogenous sources include
sewage contaminated natural waters [5]. A probable key
feature in the pathogenesis of this patient’s infectionwas the
formation of a biofilm composed mainly of host adhesins
(fibrinogen, fibronectin, collagen) and bacteria that may
have occurred soon after the insertion of the ICD [6]. The
skinof ourpatient couldhavebeen colonizedwithPRbefore
the adherence of the bacterium to the device since no foley
catheter insertion had been reported on prior admissions.
PR is a facultative anaerobe, Gram-negative, motile,
opportunistic bacterium that belongs to the genus Provi-
dencia, tribe Proteeae (along with the genus Proteus and
Morganella), Enterobacteriaceae family. PR was first
isolated by Rettger in 1904 during an epidemic of fowl
cholera, but it was only studied in detail later in 1918when
Table 1. Hematologic and blood chemistry laboratory data
Hematology Chemistry
White cell count 10.5 Sodium 138 Protein 6.2
Hemoglobin 12.1 Potassium 4.6 Albumin 3.3
Hematocrit 34.8 Chloride 105 Total Bilirrubin 0.5
Platelet 231 BUN 23 AST 40
PTT 56 Creatinine 1.2 ALT 49
Prothromin time 29.7 Glucose 89 Alk Phosp 43
INR 2.9 C Reactive protein 1.6
Ref: Partial thromboplastin time (PTT), International Normal Ratio (INR), Blood Urea Nitrogen (BUN), Aspartate aminotransferase (AST), Alanine
aminotransferase (ALT), Alkaline Phosphatase (Alk Phos).
Table 2. Resistance profile of organism isolate
Amikacin <=16 S Ciprofloxacin <=1 S
Amoxicillin/clavulanate >16/8 R Gentamicin <=4 S
Ampicillin >16 R Imipenem <=4 S
Ampicillin/sulbactam 16/8 I Levofloxacin <=2 S
Cefazolin >16 R Moxifloxacin <=2 S
Cefepime 30 S Piperacillin/tazobactam <=16 S
Cefoxitin <=8 S Ticarcillin/clavulanate <=16 S
Ceftazidime <=8 S Tobramycin <=4 S
Ceftriaxone <=8 S Trimethoprim/Sulfa >2/38 R
Ref: Susceptible (S), Intermediate (I), Resistant (R).
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it was called Bacterium rettgerei [7]. In 1951, Kauffmann
applied the term Providencia to the genus described by
Stuart et al. at Brown University in Providence, Rhode
Island [8]. Many taxonomic changes of genus Providencia
have taken place since then, which included a frequent
overlap between the Gram-negative genera belonging to
the tribe Proteeae. Currently, the genus Providencia
includes five species: P. stuartii, P. rettgeri, P. alcalifacens,
P. rustigianii and P. heimbachae. Providencia stuartii has
been described as the commonest isolate in residents of
nursing homes diagnosed with bacteremia [9]. In a recent
epidemiologic study in a Canadian population, the
incidence of isolates for the genus Providencia was found
to be 3.4⁄100 000⁄year, with more infections reported as
people aged and were residing in nursing homes [10].
Nosocomial outbreaks of highly resistant strains of PR
causing urinary tract infections and bacteremias have been
described. Epidemiologic factors included the intensive
concomitant use of antibiotics and indwelling urinary
catheters; while the use of gloves by personnel showed to
be an effective control measure [11,12]. Our patient was
kept on contact isolation until the end of the admission
with no further cases reported on the same medical ward.
Resistant Enterobacteriaceae is a recent major health
hazard. The transmission of resistance is frequently
acquired through plasmids from other Gram-negative
rods and it has been associated with the increasing use of
antibiotics. The frequent isolation of extended spectrum
beta-lactamase in Providencia species alarms about the risk
of future nosocomial epidemics caused by this multi-
resistant organism and is a considered an emerging
problem [13,14]. The natural antibiotic susceptibility of
PR includes numerous beta-lactam, fluoroquinolone and
aminoglycoside antibiotics and a less resistant pattern
than that of P. stuartii [15].
Conclusion
Infections by PR and other Gram-negative bacteria should
be considered when approaching a recent hospitalized
patient with an early automatic ICD infection, and initial
empiric antibiotic coverage for this bacterium may be
warranted. The election of the antibiotic should be guided
by culture susceptibilities given the increasing evidence of
multi-drug resistant strains.
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